Evidence map›Paper›PMID 27590471›Full record

ArticleBMC family practice2016

Comorbidities treated in primary care in children with chronic fatigue syndrome / myalgic encephalomyelitis: A nationwide registry linkage study from Norway.

Inger J Bakken, Kari Tveito, Kari M Aaberg, Sara Ghaderi, Nina Gunnes, Lill Trogstad, Per Magnus, Camilla Stoltenberg, Siri E Håberg

Open access · goldAbstract read
In one paragraph

Article in BMC family practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Inger J BakkenNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway. inger.johanne.bakken@fhi.no.ORCID 0000-0002-4176-8257
Kari TveitoNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Kari M AabergNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Sara GhaderiNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Nina GunnesNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Lill TrogstadNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Per MagnusNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Camilla StoltenbergNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Siri E HåbergNorwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, 0403, Norway.
Norwegian Institute of Public Health · NOOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a complex condition. Causal factors are not established, although underlying psychological or immunological susceptibility has been proposed. We studied primary care diagnoses for children with CFS/ME, with children with another hospital diagnosis (type 1 diabetes mellitus [T1DM]) and the general child population as comparison groups.

methodsAll Norwegian children born 1992-2012 constituted the study sample. Children with CFS/ME (n = 1670) or T1DM (n = 4937) were identified in the Norwegian Patient Register (NPR) (2008-2014). Children without either diagnosis constituted the general child population comparison group (n = 1337508). We obtained information on primary care diagnoses from the Norwegian Directorate of Health. For each primary care diagnosis, the proportion and 99 % confidence interval (CI) within the three groups was calculated, adjusted for sex and age by direct standardization.

resultsChildren with CFS/ME were more often registered with a primary care diagnosis of weakness/general tiredness (89.9 % [99 % CI 88.0 to 91.8 %]) than children in either comparison group (T1DM: 14.5 % [99 % CI: 13.1 to 16.0 %], general child population: 11.1 % [99 % CI: 11.0 to 11.2 %]). Also, depressive disorder and anxiety disorder were more common in the CFS/ME group, as were migraine, muscle pain, and infections. In the 2 year period prior to the diagnoses, infectious mononucleosis was registered for 11.1 % (99 % CI 9.1 to 13.1 %) of children with CFS/ME and for 0.5 % (99 % CI (0.2 to 0.8 %) of children with T1DM. Of children with CFS/ME, 74.6 % (1292/1670) were registered with a prior primary care diagnosis of weakness / general tiredness. The time span from the first primary care diagnosis of weakness / general tiredness to the specialist health care diagnosis of CFS/ME was 1 year or longer for 47.8 %.

conclusionsThis large nationwide registry linkage study confirms that the clinical picture in CFS/ME is complex. Children with CFS/ME were frequently diagnosed with infections, supporting the hypothesis that infections may be involved in the causal pathway. The long time span often observed from the first diagnosis of weakness / general tiredness to the diagnosis of CFS/ME might indicate that the treatment of these patients is sometimes not optimal.

Indexed as

AdolescentAnxiety DisordersChildComorbidityDelayed DiagnosisDepressive DisorderDiabetes Mellitus, Type 1Epstein-Barr Virus InfectionsFatigueFatigue Syndrome, ChronicFemaleHumansMaleMigraine DisordersMuscle WeaknessMyalgiaAdolescentsChildrenChronic fatigue syndromeDiabetesEpidemiologyInfections diseasesMultimorbidityPrimary care

Identifiers

PMID27590471
PMCPMC5010760
OpenAlexW2514513339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.